Want to join the conversation?
RBC Capital Markets analyst Glenn Novarro asks $ABT what the upside surprises are within the $STJ portfolio over next 5 years. CEO Miles White says $ABT is optimistic about the uptick, penetration & introduction of products. But reimbursements or timing of an approval could slow down the company in delivering its products on time & on schedule.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.